SS

Seema Shukla

Director Director DIN 09115812
DIN 09115812 First appointment Mar 2021
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Seema Shukla

Data last updated:

Seema Shukla was a Director at Healthavenue Medicare Services Private Limited (2024–2025) and Director at Progress Medical Solutions (Opc) Private Limited (from 2021).

DIN 09115812
Primary Designation Director
First Appointment 20 Mar 2021
Oldest Company Age 5 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jan 20242024₹17.2 Lakh (FY 2025)Active
Director20 Mar 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Progress Medical Solutions (Opc) Private Limited
Healthavenue Medicare Services Private Limited
Premium access

Shareholding and investment profile for Seema Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seema Shukla

Seema Shukla was first appointed on 20 Mar 2021 as Director at Progress Medical Solutions (Opc) Private Limited. The most recent appointment on record is 01 Jan 2024 at Healthavenue Medicare Services Private Limited.

Seema Shukla held 2 earlier board appointments: Healthavenue Medicare Services Private Limited (Director, 01 Jan 2024 to 14 Jul 2025); Progress Medical Solutions (Opc) Private Limited (Director, from 20 Mar 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available